Creating novel amino acid nanoparticles with enhanced anticancer activity

Researchers use nanoparticles made of UV light crosslinked amino acids, loaded with doxorubicin and coated with tannic acid complex to target cancer cells

2024-01-09

(Press-News.org)

Ishikawa, Japan -- Amino acids, such as tyrosine and tryptophan, are the fundamental building blocks that make up proteins. These biomolecules have different chemical groups on each end and side chain, and so, have the natural ability to form a chain through the formation of an amide (peptide) bond. However, such linkages are weak and easily degraded under physiological conditions. This is where the Fmoc-protected amino acids come into the picture.

In a new study now, a research team led by Dr. Eijiro Miyako, Associate Professor, Japan Advanced Institute of Science and Technology (JAIST) and Dr. Alberto Bianco and Dr. Cécilia Ménard-Moyon from the Centre National de la Recherche Scientifique (CNRS), France, employed ultraviolet light at 254 nm (leading to CBPUV nanoparticles) and riboflavin-mediated crosslinking at 365 nm (leading to CBPRibo nanoparticles) to crosslink the Fmoc-protected amino acids. “Amino acids being the building blocks of proteins have numerous advantages, such as better biocompatibility. Therefore, we wanted to create novel self-assembled amino acid-based nanoparticles which can be triggered through multiple mechanisms,” says Dr. Eijiro Miyako, explaining the motivation behind their research. The findings of this study are published in Small.

The self-assembled amino acids were stably crosslinked dimers of Fmoc-Tyr-OH (Tyrosine) and Fmoc-Trp-OH (Tryptophan). Doxorubicin, an anticancer drug, was subsequently loaded into the crosslinked amino acid nanoparticles. To increase the stability of the nanoparticles, the researchers used a tannic acid-Iron (Fe3+) complex (or TAF) as the outer layer of coating. This coating can degrade inside the cells through the glutathione enzymatic release or by pH difference in the tumor microenvironment. The tannic acid coating can be also used in photothermal anticancer therapy, where external light can increase the local temperature surrounding the cancer tissue, causing cancer cell death.

The synthesized nanoparticles were then extensively studied for their structural integrity, stability, and drug release under different pH conditions. The functional profile, cellular uptake, and biocompatibility of self-assembled amino acid nanoparticles were then studied using cell culture techniques. Finally, the anticancer efficacy of synthesized nanoparticles was analyzed in tumor-bearing mice. The combined approach of chemotherapy, due to doxorubicin action, and photothermal therapy thanks to the tannic acid coating, showed excellent anticancer activity.

Post crosslinking, the amino acid-based nanoparticles showed notable changes in color, size, absorbance, fluorescence, and thermal stability. Furthermore, CBPUV exhibited superior stability after crosslinking, compared to CBPRibo. CBPUV also consistently maintained its structure, while CBPRibo showed partial disassembly, forming hollow spheres. Drug release study revealed minimal drug release under physiological pH (7.4), indicating that stable coating is crucial for in vivo delivery. At pH 5.5, incomplete coating degradation resulted in negligible drug release. However, the addition of glutathione (GSH) at pH 5.5 significantly boosted drug release by triggering TAF coating degradation, indicating GSH/pH responsiveness. The combined acidic and GSH treatment intensified coating degradation. This responsive behavior enables controlled drug release in specific physiological conditions. Furthermore, in vitro assessments revealed concentration-dependent cytotoxicity and improved efficacy in combined chemo/photothermal therapy. In vivo studies on tumor-bearing mice showcased significant tumor growth inhibition, indicating promising anticancer effects without observed side effects.

Sharing his concluding thoughts about the study findings, Dr. Miyako says, “Nanotechnology holds promise of transforming basic laboratory science into a powerful tool for combating complex diseases like cancer. We are optimistic that this pioneering research will advance, potentially evolving into cutting-edge cancer treatment technology ready for clinical trials within ten years."

Going ahead, the development of these self-assembled amino acid nanoparticles can help in fighting critical issues such as multi-drug resistance in cancer and improve the overall efficacy of treatment outcomes.

###

Reference

Title of original paper: Photocrosslinked Co-assembled Amino Acid Nanoparticles for Controlled Chemo/photothermal Combined Anticancer Therapy

Authors:

Tengfei Wang, Yun Qi, Eijiro Miyako*, Alberto Bianco*, Cécilia Ménard-Moyon*

Journal

Small

DOI:

10.1002/smll.202307337

About Japan Advanced Institute of Science and Technology, Japan

Founded in 1990 in Ishikawa prefecture, the Japan Advanced Institute of Science and Technology (JAIST) was the first independent national graduate school in Japan. Now, after 30 years of steady progress, JAIST has become one of Japan’s top-ranking universities. JAIST counts with multiple satellite campuses and strives to foster capable leaders with a state-of-the-art education system where diversity is key; about 40% of its alumni are international students. The university has a unique style of graduate education based on a carefully designed coursework-oriented curriculum to ensure that its students have a solid foundation on which to carry out cutting-edge research. JAIST also works closely both with local and overseas communities by promoting industry–academia collaborative research.

About Associate Professor Eijiro Miyako from Japan Advanced Institute of Science and Technology, Japan

Dr. Miyako Eijiro is an Associate Professor at the Materials Chemistry Frontiers Research Area, Japan Advanced Institute of Science and Technology (JAIST). He has been a visiting scientist at Centre National de la Recherche Scientifique (CNRS) (France) and Nanyang Technological University (Singapore). He also served as the Senior Researcher at National Institute of Advanced Industrial Science and Technology (AIST), Japan. His research interests are in the areas of Bioengineering, Materials Chemistry, Nanotechnology, and Nanomedicine. Dr. Miyako received his Ph.D. in Chemical Systems and Engineering from Kyushu University (Japan) in 2006. He has received research prizes and awards such as PCCP Prize in Royal Society of Chemistry and Research Encouragement Award in The Fullerenes, Nanotubes and Graphene Research Society.

Funding information

This work was supported by the Centre National de la Recherche Scientifique (CNRS), by the Agence Nationale de la Recherche (ANR) through the LabEx project Chemistry of Complex Systems (ANR-10-LABX-0026_CSC) and by Jean-Marie Lehn Foundation. The author also thanks Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (A) (Grant number 23H00551), JSPS KAKENHI Grant-in-Aid for Challenging Research (Pioneering) (Grant number 22K18440), the Japan Science and Technology Agency for Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Grant Number JPMJTR22U1), Institute for Fermentation, Osaka (IFO), and the Uehara Memorial Foundation.

END

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

A landscape-based approach to urban heritage management: People, spatial biography, and ecosystem

2024-01-09

This article first identifies the current definition of urban heritage that includes both “old” and “young” monuments. Their protection has also shifted from solely preserving “old” values into a more holistic process to retain “old” values and manage the change in their adaptive reuse to gain “new” values, towards a more people-centered and landscape-based approach. Furthermore, a concept of ecosystem for urban planning and development is introduced, ...

Photostimulation: non-invasive and effective therapeutic approach for Alzheimer’s disease

2024-01-09

Alzheimer’s disease (AD) is an age-related neurodegenerative disorder. β-amyloid (Aβ) deposition in the brain is a crucial contributor to the pathogenesis of AD, mitigating excessive cerebral Aβ burden has been considered as a possible therapeutic strategy for AD. Meningeal lymphatic vessels (MLVs) are recently discovered structures responsible for exchanging soluble components between the cerebrospinal fluid and interstitial fluid, and have been proved to be a potential pathway of Aβ drainage. Researchers at Huazhong University ...

Love scrambles the brain and scientists can now tell us why

2024-01-09

Love is blind, the saying goes, and thanks to a world-first Australian study, we are now a step closer to understanding why. It is well known that romantic love changes the brain, releasing the so-called love hormone oxytocin, responsible for the euphoria we feel when falling in love. Now, researchers from the ANU, University of Canberra and University of South Australia have measured how a part of the brain is responsible for putting our loved one on a pedestal in that first flush of romance. In the world’s first study investigating the link between the human brain’s behavioural activation ...

Where to go with nitrate electroreduction reaction?

2024-01-09

Ammonia is a necessary feedstock to produce nitrogen-based fertilizers, chemicals, pharmaceuticals, and polymers. To date, about 80% of global ammonia is used to produce nitrogen-based fertilizers which relates to 50% of global food production. The global production of ammonia is about 180 million metric tons per year through the carbon-intensive and highly energy-consuming Haber-Bosch process. The high energy consumption, high carbon intensity, and high capital investment of the Haber-Bosch process make the development of environmentally sustainable and affordable routes for ammonia synthesis under ambient conditions more urgent. The electrochemical ammonia ...

Measuring grass pollen allergens instead of grass pollen count will help hay fever sufferers

2024-01-09

Measuring airborne grass allergen levels instead of pollen counts will be more beneficial for hay fever sufferers as new research shows grass allergen levels are more consistently associated with hay fever symptoms than grass pollen counts. The research, published today in The Journal of Allergy and Clinical Immunology and led by King’s College London and Imperial College London, shows for the first time that measuring airborne allergen levels will help people with hay fever better control their symptoms. 1 in 4 adults in the UK suffer from hay fever from late-March to September. Symptoms include a runny or blocked ...

Clear link between autoimmune disease and perinatal depression

2024-01-09

Women with autoimmune disease are more likely to suffer from depression during pregnancy and after childbirth; conversely, women with a history of perinatal depression are at higher risk of developing autoimmune disease, a new study from Karolinska Institutet published in the journal Molecular Psychiatry reports. In autoimmune disease, the immune system mistakenly attacks the body’s own healthy tissue. Some of the most common autoimmune diseases are gluten intolerance (coeliac disease), autoimmune thyroiditis, rheumatoid ...

Diagnostic errors are common in seriously ill hospitalized adults

2024-01-09

A study of seriously ill patients from academic medical centers across the country has found that nearly a quarter had a delayed or missed diagnosis. All the patients had either been transferred to the intensive care unit (ICU) after being admitted or died in the hospital. The researchers concluded that three-quarters of these diagnostic errors contributed to temporary or permanent harm, and that diagnostic errors played a role in about one in 15 of the deaths. The most common errors identified in the study involved delayed rather than missed diagnoses, for example because a specialist was consulted too late or an alternate diagnosis was not considered ...

Scripps Research scientists give new insight into a molecular target of alcohol

2024-01-09

LA JOLLA, CA— Ethanol—the compound found in alcoholic beverages—interferes with the normal functioning of a long list of biological molecules, but how each of these interactions contributes to the behavioral effects of alcohol is not fully understood. A guiding, but elusive, goal of researchers is to identify the protein (or proteins) to which ethanol binds that makes some people vulnerable to excessive drinking. Solving this question would point the way to effective therapies for alcohol use disorder, ...

Coastal populations set to age sharply in the face of climate migration, FSU researcher finds

2024-01-09

As climate change fuels sea level rise, younger people will migrate inland, leaving aging coastal populations — and a host of consequences — in their wake, a study by Florida State University researchers finds. While destination cities will work to sustainably accommodate swelling populations, aging coastal communities will confront stark new challenges, including an outflow of vital human infrastructure such as health care workers, said Associate Professor of Sociology Matt Hauer, lead author of the study published in the Proceedings of the National Academy of ...

World-renowned surgeon named new director of Moores Cancer Center at UC San Diego Health

2024-01-09

Following an extensive national search, Diane M. Simeone, MD, has been appointed director of Moores Cancer Center at UC San Diego Health, effective April 1, 2024. Simeone brings robust institutional, national and international leadership experience to both oncologic patient care and scientific research, with a focus on establishing novel models of interdisciplinary collaboration. She is an internationally recognized surgeon-expert in the biology and multidisciplinary treatment of pancreatic neoplasms, with an active clinical practice in pancreatic surgery. Simeone currently serves as the Laura and Isaac Perlmutter ...

Creating novel amino acid nanoparticles with enhanced anticancer activity

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: